Alvine Pharmaceuticals
San Carlos · Founded 2005
About Alvine Pharmaceuticals
Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.
Company Facts
- Founded: 2005
- Legal name: Alvine Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $68.0M
- Funding stage: M&A
- Last round: Debt Financing (Jan 2013)
- Website: alvinepharma.com
- Phone: 6505962429
Social Profiles
Canonical: https://fsome.com/organization/alvine-pharmaceuticals-8419632 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.